| abstract |
The present invention relates to (a) one or more antigen binding domains capable of specifically binding to fibroblast activation protein (FAP) comprising (a) FAP clone 212 or a variant thereof, and (b) one capable of specifically binding to CD40. It relates to novel bispecific antigen binding molecules comprising the above antigen binding domains, methods of producing these molecules, and methods of using them. |